The largest database of trusted experimental protocols

Mmp 3 sirna

Manufactured by Thermo Fisher Scientific
Sourced in United States

MMP-3 siRNA is a small interfering RNA (siRNA) product designed to target and silence the expression of the MMP-3 gene. MMP-3, also known as stromelysin-1, is a member of the matrix metalloproteinase (MMP) family of enzymes that play a role in the breakdown of extracellular matrix components. The MMP-3 siRNA product can be used in research applications to study the functional role of MMP-3 in various biological processes.

Automatically generated - may contain errors

2 protocols using mmp 3 sirna

1

Transfection and Nano-CuO Exposure Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfection was performed as described in our previous study with modifications [13 (link)]. Briefly, BEAS-2B cells were seeded in the inserts and incubated for 12 h, then U937* cells were seeded at a ratio of 1:1 or 9:1 (BEAS-2B:U937*) onto the BEAS-2B cell layer in antibiotic-free medium supplemented with 10% FBS and allowed to attach. Cells were then transfected with a mixture of 6 µL of TurboFectin 8.0 Transfection Reagent (Origene, Rockville, MD, USA) and 30 nM of MMP-3 siRNA (Ambion, Carlsbad, CA, USA) in a total volume of 1 mL antibiotic-free and FBS-free medium for 6 h. Afterward, 1 mL medium containing 2 times FBS and antibiotics was added, and the cells were incubated for another 12 h. Silencer™ Select Negative Control No. 2 siRNA (Ambion, Carlsbad, CA, USA) was used as a negative control. After exposure to Nano-CuO for 12 h, the conditioned media were collected and the roles of MMP-3 in the cleavage of OPN and activation of fibroblasts were determined.
+ Open protocol
+ Expand
2

Nano-CuO Induced EMT and MMP-3 Silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transfection was performed following the protocol provided by Thermo Fisher. Briefly, 1.5 × 105 BEAS-2B cells per well were seeded into six-well plates in antibiotic-free RPMI1640 supplemented with 10% FBS. The cells were incubated until 70-80% confluency. Cells were then transfected with a mixture of 6 μL of TurboFectin 8.0 Transfection Reagent (Origene, Rockville, MD) and 40 nM of MMP-3 siRNA (Ambion, Carlsbad, CA) in a total volume of 2 mL antibiotic-free and FBS-free RPMI 1640 medium for 24 h. After transfection, the cells were treated with Nano-CuO for another 48 h. The transfection efficiency was determined by MMP-3 expression by Western blot, and the cells were also harvested for Western blot to examine the role of MMP-3 in Nano-CuO-induced EMT. Silencer™ Select Negative Control No. 2 siRNA (Ambion, Carlsbad, CA) was used as a negative control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!